Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke
Intravenous (IV) tissue plasminogen activator (tPA) is the only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke. Post tPA patients are typically monitored in an intensive care unit (ICU) for at least 24 hours. However, rigorous evidence to support this practice is lac...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | angličtina |
| Vydáno: |
2014
|
| On-line přístup: | https://doi.org/10.1371/journal.pone.0088652 https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0088652&type=printable |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|